Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rowan Frunt

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Thrombosis and Haemostasis : JTH|April 30, 2023
Taking aim at titaniumRowan Frunt, Simone Smits, Coen Maas
Blood Cancer Journal|March 2, 2021
Therapeutic outcome of early-phase clinical trials in multiple myeloma: a meta-analysisNiels van Nieuwenhuijzen, Rowan Frunt, Anne M May, et al.
Journal of Thrombosis and Haemostasis : JTH|June 19, 2024
Factor XII contact activation can be prevented by targeting 2 unique patches in its epidermal growth factor-like 1 domain with a nanobodyRowan Frunt, Hinde El Otmani, Simone Smits, et al.
Thrombosis and Haemostasis|September 27, 2022
Factor XII Explored with AlphaFold - Opportunities for Selective Drug DevelopmentRowan Frunt, Hinde El Otmani, Bubacarr Gibril Kaira, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 20, 2024
Biofluid specific protein coronas affect lipid nanoparticle behavior in vitroDemian van Straten, Helena Sork, Luuk van de Schepop, et al.
Blood|January 25, 2024
Plasmin-cleaved von Willebrand factor as a biomarker for microvascular thrombosisHinde El Otmani, Rowan Frunt, Simone Smits, et al.
Journal of Extracellular Vesicles|December 18, 2024
EV-Elute: A universal platform for the enrichment of functional surface marker-defined extracellular vesicle subpopulationsWillemijn S de Voogt, Rowan Frunt, Raul M Leandro, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Thrombosis and Haemostasis : JTH|April 30, 2023
Taking aim at titaniumRowan Frunt, Simone Smits, Coen Maas
Blood Cancer Journal|March 2, 2021
Therapeutic outcome of early-phase clinical trials in multiple myeloma: a meta-analysisNiels van Nieuwenhuijzen, Rowan Frunt, Anne M May, et al.
Journal of Thrombosis and Haemostasis : JTH|June 19, 2024
Factor XII contact activation can be prevented by targeting 2 unique patches in its epidermal growth factor-like 1 domain with a nanobodyRowan Frunt, Hinde El Otmani, Simone Smits, et al.
Thrombosis and Haemostasis|September 27, 2022
Factor XII Explored with AlphaFold - Opportunities for Selective Drug DevelopmentRowan Frunt, Hinde El Otmani, Bubacarr Gibril Kaira, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 20, 2024
Biofluid specific protein coronas affect lipid nanoparticle behavior in vitroDemian van Straten, Helena Sork, Luuk van de Schepop, et al.
Blood|January 25, 2024
Plasmin-cleaved von Willebrand factor as a biomarker for microvascular thrombosisHinde El Otmani, Rowan Frunt, Simone Smits, et al.
Journal of Extracellular Vesicles|December 18, 2024
EV-Elute: A universal platform for the enrichment of functional surface marker-defined extracellular vesicle subpopulationsWillemijn S de Voogt, Rowan Frunt, Raul M Leandro, et al.
Pageof 1